{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:51:58Z","timestamp":1792806718739,"version":"4.5.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151543","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T17:53:10Z","timestamp":1458064390000},"page":"e0151543","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin"],"prefix":"10.1371","volume":"11","author":[{"given":"Zahra","family":"Kashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolkarim","family":"Mahrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvarsadat","family":"Kianmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1462-8902.2004.00325.x","article-title":"The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes","volume":"6","author":"JB Buse","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","article-title":"Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials","volume":"332","author":"J Costa","year":"2006","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11892-001-0025-7","article-title":"Drugs for cardiovascular risk reduction in the diabetic patient","volume":"1","author":"DSH Bell","year":"2001","journal-title":"Curr Diabetes Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1463-1326.2008.01031.x","article-title":"Metformin\u2013the gold standard in type 2 diabetes: what does the evidence tell us?","volume":"11","author":"E Bosi","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diabres.2015.01.024","article-title":"The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin","volume":"108","author":"Z Kashi","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"H Noto","year":"2012","journal-title":"PLoS ONE"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.bcp.2010.08.021","article-title":"Mechanisms of metformin action on glucose transport and metabolism in human adipocytes","volume":"80","author":"J Grisouard","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-014-0283-8","article-title":"The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study","volume":"15","author":"A Mahrooz","year":"2015","journal-title":"Clin Exp Med"},{"issue":"Suppl 2","key":"ref9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1046\/j.1463-1326.1999.0010s2001.x","article-title":"Impact of the new WHO classification and diagnostic criteria","volume":"1","author":"PH Bennet","year":"1999","journal-title":"Diabetes Obes Metabolism"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10038-006-0087-0","article-title":"Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin","volume":"52","author":"E Shikata","year":"2007","journal-title":"J Hum Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/dc09-1727","article-title":"The effect of oral antidiabetic agents on A1C levels","volume":"33","author":"D Sherifali","year":"2010","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"A Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedwald","year":"1972","journal-title":"Clin Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.amjmed.2010.03.024","article-title":"Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events","volume":"123","author":"M Rubenfire","year":"2010","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"HN Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.canlet.2005.06.051","article-title":"Implications of genetic polymorphisms in drug transporters for pharmacotherapy","volume":"234","author":"R Kerb","year":"2006","journal-title":"Cancer Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1474651410397583","article-title":"Therapy with oral antidiabetic drugs: applied pharmacogenetics","volume":"11","author":"A Holstein","year":"2011","journal-title":"Br J Diabetes Vasc Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.23103","article-title":"Expression of organiccation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver","volume":"50","author":"AT Nies","year":"2009","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/14622416.9.4.415","article-title":"Polymorphism in human organic cation transporters and metformin action","volume":"9","author":"H Takane","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/07853890.2010.549144","article-title":"Disposition of metformin: variability due to polymorphisms of organic cation transporters","volume":"44","author":"O Zolk","year":"2012","journal-title":"Ann Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.01.018","article-title":"Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics","volume":"77","author":"M Niemi","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Y Shu","year":"2007","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","author":"J Konig","year":"2006","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1373\/clinchem.2004.037556","article-title":"Relationship between serum lipoprotein ratios and insulin resistance in obesity","volume":"50","author":"A Brehm","year":"2004","journal-title":"Clin Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.27.1.141","article-title":"One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes","volume":"27","author":"M Hanefeld","year":"2004","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.diabet.2010.01.010","article-title":"Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women","volume":"36","author":"GM Hosain","year":"2010","journal-title":"Diabetes Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T05:31:51Z","timestamp":1600320711000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151543"}},"subtitle":[],"editor":[{"given":"Yanqiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151543","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]}}}